Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that PharosAI, a research ...
REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...
The CeliacDx offering for Texas marks the company’s first outreach to physicians with additional states planned for later this year. The expansion into physician-ordered testing furthers Targeted ...
In January 2026, CareDx reported past-quarter revenue growth of 25% year over year and 14% for the full year, and announced a new collaboration with 10x Genomics to research transplant organ rejection ...
PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report ...
How CRISPR and functional genomics are used to establish causality, understand disease mechanisms and guide early drug ...
Forbes contributors publish independent expert analyses and insights. Steven covers accessibility and assistive technologies. Aug 07, 2023, 01:54pm EDT Aug 07, 2023, 03:58pm EDT This article is more ...
Spanish cancer biomarker medtech Reveal Genomics has boosted the roles of three of its founding members. | Spanish cancer biomarker medtech Reveal Genomics has boosted the roles of three of its ...
Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of ...
In a country where healthcare often begins after illness strikes, genomics is quietly changing the script. Speaking to Aditi Ohri, co-founder of Mr Yoda, CE exp ...
Long-read genome sequencing is being integrated early into ASO therapy development to capture complex genetic variants missed ...
Cathie Wood's ARK sold $2.78M Twist Bioscience, bought Tempus AI & WeRide Jan 26. Full breakdown of ARK Invest's latest AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results